Rubrik stock slips again after CFO sale filing — what to watch before Monday’s open

Rubrik stock slips again after CFO sale filing — what to watch before Monday’s open

NEW YORK, Jan 10, 2026, 18:42 EST — Market closed.

  • Rubrik shares closed Friday 1.6% lower at $70.56, following a steep 6.8% fall on Thursday.
  • An SEC filing revealed that CFO Kiran Kumar Choudary offloaded 3,500 shares this week, following a pre-set trading plan.
  • Upcoming triggers: Tuesday’s U.S. CPI report and Rubrik’s earnings scheduled for March.

Rubrik, Inc. shares dropped again Friday, ending down 1.55% at $70.56. The stock had already slipped 6.76% on Thursday, leaving it under pressure heading into the weekend. (StockAnalysis)

The underperformance was notable as Wall Street’s leading indexes hit new highs, buoyed by a robust U.S. jobs report that drew funds back into stocks.

This matters more than ever as the calendar turns grim for software stocks sensitive to interest rates. With markets closed until Monday, traders have limited options to manage risk ahead of crucial data likely to swing bond yields sharply.

A Form 4 filing with the U.S. Securities and Exchange Commission revealed that Rubrik CFO Kiran Kumar Choudary sold 3,500 Class A shares on Jan. 7, with prices averaging between $75.49 and $77.50. According to the filing, the sales were conducted under a Rule 10b5-1 trading plan put in place in January 2025. After these transactions, Choudary still held 504,959 shares.

Chart watchers note Rubrik’s stock has fallen beneath key moving averages, with the 50-day sitting near $75.20 and the 200-day around $81.51. These marks often serve as resistance on any rebound attempt. (MarketBeat)

Form 4 reports must disclose insider trades. A 10b5-1 plan, meanwhile, sets a predetermined trading schedule to disconnect selling decisions from daily market fluctuations.

Rubrik offers data protection and cyber recovery software designed to help businesses secure and recover data following attacks. The company’s latest quarterly report showed subscription annual recurring revenue (ARR)—a key metric for contracted subscription income—jumped 34% to $1.35 billion. Revenue also surged 48%, reaching $350.2 million. (Rubrik)

Rubrik’s fiscal year wraps up on Jan. 31, so the current quarter is just weeks from closing. All eyes remain on whether the company can keep growing while trimming its losses. (SEC)

Rubrik hasn’t officially announced its next earnings date yet. MarketBeat, however, estimates the report will drop after the market closes on March 12, following the company’s usual timing. (MarketBeat)

U.S. markets, however, will be focused on the upcoming inflation data. The Bureau of Labor Statistics is set to release December 2025 CPI figures on Jan. 13 at 8:30 a.m. Eastern. (Bureau of Labor Statistics)

If inflation heats up beyond forecasts, Treasury yields might spike, putting pressure on high-growth tech stocks—even without new corporate updates. The tech-heavy Nasdaq has already demonstrated how fast sentiment can shift when investors adjust their rate expectations.

U.S. trading kicks off Monday, with Rubrik investors focused on whether the stock can stay above $70 ahead of Tuesday’s CPI report on Jan. 13.

Stock Market Today

  • Opendoor Rebound Hopes Rise as Trump Mortgage-Bond News Spurs Housing Stocks
    January 11, 2026, 11:37 AM EST. Opendoor Technologies (OPEN) has drawn renewed attention after a Trump plan to repurchase about $200 billion in mortgage securities spurred buying in housing stocks. The late-2023 meme-stock surge for Opendoor has cooled among retail investors, but the latest government-bond news could rekindle interest. The plan would have Fannie Mae and Freddie Mac buy the securities to push down rates, a move traders linked to housing equities welcomed with a roughly 5% intraday gain. Opendoor traded near $7.29, with a $7.0B market cap and a 52-week range of $0.51-$10.87. Some see potential for further sentiment-driven moves; others warn gains may diverge from fundamentals. Existing holders may ride the near term; new buyers should tread carefully, given the stock's volatility and valuation gaps.
NovaBay Pharmaceuticals stock doubles as NBY volatility flares again — what to watch next
Previous Story

NovaBay Pharmaceuticals stock doubles as NBY volatility flares again — what to watch next

Ondas Holdings stock in focus after $1 billion premium stock-and-warrant sale
Next Story

Ondas Holdings stock in focus after $1 billion premium stock-and-warrant sale

Go toTop